#FacesOfMyeloma: a story of hope and adaptation with Wouter
My name is Wouter, I am living in The Netherlands, and I am 55 years old. In March 2024, I was diagnosed with myeloma, which turned my world upside down. One of the biggest challenges…
My name is Wouter, I am living in The Netherlands, and I am 55 years old. In March 2024, I was diagnosed with myeloma, which turned my world upside down. One of the biggest challenges…
We are proud to highlight the work of one of our Polish members, Fundacja Carita, which recently organised the European Forum of Hemato-Oncological Patients. This forum brought together experts and stakeholders to discuss crucial topics…
The European Young Myeloma Patients Group, created by Myeloma Patients Europe (MPE), invites you to a webinar focused on myeloma and physical fitness on Wednesday, 26 February 2025, from 16:00 – 17:00 CET. This session…
At the 2024 American Society of Hematology (ASH) Annual Meeting, Myeloma Patients Europe (MPE) interviewed experts about the most interesting studies and abstracts in myeloma and AL amyloidosis research that were presented during the conference.…
Myeloma Patients Europe (MPE) is proud to present its Year in Review 2024, highlighting achievements and milestones that reflect our commitment to improving outcomes and quality of life for myeloma and AL amyloidosis patients. This…
The American Society of Hematology (ASH) Annual Meeting, the world’s largest haematology conference, will take place from 7 – 10 December in San Diego, United States. It is a very exciting event for the myeloma…
Myeloma Patients Europe (MPE) will host a webinar covering key updates on myeloma and AL amyloidosis presented at the American Society of Hematology (ASH) Annual Meeting, which will take place from 7–10 December 2024 in…
This week MPE provided feedback on the draft of the fifth implementing act (out of six planned to be adopted this year) paving the road for the application of the Health Technology Assessment (HTA) Regulation…